Cargando…
Programmed death-1in cancer stem cells may serve as a novel immunotherapy marker
Autores principales: | Baban, Babak, Liu, Jun Yao, Zheng, Mei, Lee, Jeffrey, Grochowska, Karolina, Mozaffari, Mahmood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125887/ http://dx.doi.org/10.1186/1878-5085-5-S1-A115 |
Ejemplares similares
-
Apoptosis of stem cells likely determines the manifestation of type 2 diabetic nephropathy: predictive and preventive potentials
por: Mozaffari, Mahmood S, et al.
Publicado: (2014) -
GADD153 as a novel molecular fingerprint for Sjögren’s syndrome
por: Mozaffari, Mahmood S, et al.
Publicado: (2014) -
Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153
por: Baban, Babak, et al.
Publicado: (2015) -
New strategies to advance pre/diabetes care: integrative approach by PPPM
por: Mozaffari, Mahmood S
Publicado: (2014) -
Analysis of proteins involved in programmed cell death in Hemerocallis petals
por: Tomkins, Jeffrey P, et al.
Publicado: (2005)